Recombinant factor VIIa use in acute type A aortic dissection repair: A multicenter propensity-score-matched report from the Nordic Consortium for Acute Type A Aortic Dissection
The Journal of thoracic and cardiovascular surgery, Volume 154, Issue 6, 2017, Pages 1852
In this propensity-matched cohort study of patients undergoing ATAAD surgery, treatment with rFVIIa for major bleeding was not associated with a significantly increased risk of stroke, RRT, or mortality.
Full Text (Upload PDF)
PPT (Upload PPT)